Italian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
hepatic encephalopathy/diarrea
Il collegamento viene salvato negli appunti
Pagina 1 a partire dal 57 risultati
Hepatic coma induced by high protein therapy and by diarrhea; two case reports.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Production and oxidation of short-chain fatty acids in the human colon: implications for antibiotic-associated diarrhea, ulcerative colitis, colonic cancer, and hepatic encephalopathy.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Treatment of chronic portal-systemic encephalopathy with lactose in lactase-deficient patients.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
A controlled cross-over clinical comparison of lactose (50 g twice a day) versus neomycin (3 g/day) plus milk of magnesia, was carried out in ten cirrhotic patients with chronic portal-systemic encephalopathy and documented lactase deficiency. Serial semiquantitative assessments were done including:
In vitro and in vivo lactose and lactulose effects on colonic fermentation and portal-systemic encephalopathy parameters.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Lactose intolerance occurs in the majority of human groups, excluding people from Northern Europe. Because its effect is similar to that of lactulose, lactose seems to be an alternative treatment for patients with portal-systemic encephalopathy (PSE) and lactase deficiency. The mechanism of action
Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Irritable bowel syndrome (IBS) is a chronic, functional bowel disorder characterized by abdominal pain or discomfort and altered bowel habit. The pathophysiology is unclear, but may include altered gut motility, visceral hypersensitivity, abnormal central pain processing, chronic low-grade
Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: results of a meta-analysis.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Lactitol (beta-galactosido-sorbitol) has been recently compared with lactulose for the treatment of chronic hepatic encephalopathy in a few studies, each comprising a small number of patients. The results are controversial. We studied the efficiency and tolerance of both compounds by using a
Beneficial effect of carbohydrate maldigestion induced by a disaccharidase inhibitor (AO-128) in the treatment of chronic portal-systemic encephalopathy. A double-blind, randomized, controlled trial.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND
The most widely used treatment of portal-systemic encephalopathy (PSE) is the administration of oral, non-absorbable disaccharides. Theoretically, the inhibition of intestinal disaccharidases should induce malabsorption of disaccharides and increase delivery of undigested carbohydrates to
Lack of Clostridium difficile infection in patients treated with rifaximin for hepatic encephalopathy: a retrospective analysis.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
OBJECTIVE
The purpose of this study was to assess the incidence of Clostridium difficile infection in patients who received rifaximin for the treatment of hepatic encephalopathy (HE).
METHODS
Medical charts of patients who received rifaximin for the treatment of HE were reviewed. The number of
[Rifaximin for hepatic encephalopathy in children. Case report].
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Rifaximin is an antibiotic recently approved for the treatment of hepatic encephalopathy in adults. In children more than 12 year-old, it has been approved for travelers' diarrhea and it is also widely used in inflammatory bowel disease. We report, to our knowledge, the first case of a pediatric
Rifaximin, a nonabsorbed oral antibiotic, in the treatment of hepatic encephalopathy: antimicrobial activity, efficacy, and safety.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
The nonabsorbed (< 0.4%) oral antibiotic rifaximin, which has been available for enteric bacterial conditions for more than a decade in several countries outside the United States, was recently introduced in the United States for the treatment of travelers' diarrhea, and is being evaluated in
Considerations for the cost-effective management of hepatic encephalopathy.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Hepatic encephalopathy (HE) is a neuropsychiatric complication commonly associated with liver disease, namely cirrhosis. The inability of the liver to metabolize ammonia results in a buildup of ammonia, which can cross the blood-brain barrier and cause significant neurocognitive impairment. Up to
Rhubarb-based Chinese herbal formulae for hepatic encephalopathy: a systematic review and Meta-analysis.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Nightly high dose lactulose infusion could be a cost-effective treatment for hepatic encephalopathy, renal insufficiency and heart failure.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Lactulose is an established remedy for hepatic encephalopathy and shows efficacy for chronic renal insufficiency, reducing volume overload, uremia and hyperkalemia. Potentially lactulose could also be used for non-diuretic treatment of congestive heart failure. However, use of lactulose is limited
Hepatic encephalopathy: a review of its pathophysiology and treatment.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Hepatic encephalopathy (HE) is a broad spectrum of neuropsychiatric manifestations usually affecting individuals with end-stage liver disease. The presence of HE is a poor prognostic sign, with 1-year mortality rates of almost 60%. There is much debate about the underlying mechanisms that result in
Impact of pretransplant hepatic encephalopathy on liver posttransplantation outcomes.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Patients with cirrhosis commonly experience hepatic encephalopathy (HE), a condition associated with alterations in behavior, cognitive function, consciousness, and neuromuscular function of varying severity. HE occurring before liver transplant can have a substantial negative impact on
Il database di erbe medicinali più completo supportato dalla scienza
- Funziona in 55 lingue
- Cure a base di erbe sostenute dalla scienza
- Riconoscimento delle erbe per immagine
- Mappa GPS interattiva - tagga le erbe sul luogo (disponibile a breve)
- Leggi le pubblicazioni scientifiche relative alla tua ricerca
- Cerca le erbe medicinali in base ai loro effetti
- Organizza i tuoi interessi e tieniti aggiornato sulle notizie di ricerca, sperimentazioni cliniche e brevetti
Digita un sintomo o una malattia e leggi le erbe che potrebbero aiutare, digita un'erba e osserva le malattie ei sintomi contro cui è usata.
* Tutte le informazioni si basano su ricerche scientifiche pubblicate
